Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 6792484, 3 pages
http://dx.doi.org/10.1155/2016/6792484
Research Article

Clinical Behavior of Bladder Urothelial Carcinoma in Young Patients: A Single Center Experience

Department of Urology, Dokuz Eylul University School of Medicine, 35330 Izmir, Turkey

Received 20 December 2015; Revised 1 June 2016; Accepted 3 July 2016

Academic Editor: Stanley Bruce Malkowicz

Copyright © 2016 Volkan Sen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Babjuk, M. Burger, R. Zigeuner et al., “EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013,” European Urology, vol. 64, no. 4, pp. 639–653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Witjes and K. Hendricksen, “Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results,” European Urology, vol. 53, no. 1, pp. 45–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Hayat, N. Howlader, M. E. Reichman, and B. K. Edwards, “Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program,” Oncologist, vol. 12, no. 1, pp. 20–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. F. Lynch and M. B. Cohen, “Urinary system,” Cancer, vol. 75, no. 1, pp. 316–329, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Gunlusoy, Y. Ceylan, T. Degirmenci et al., “Urothelial bladder cancer in young adults: diagnosis, treatment and clinical behaviour,” Canadian Urological Association Journal, vol. 9, no. 9-10, pp. E727–E730, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Huang, M. Sun, X. Li, and J. Jin, “Urothelial carcinoma of the bladder in patients aged 30 years or younger: clinicopathological analysis and expression of fibroblast growth factor receptor 3 (FGFR3) of 45 cases,” Medical Oncology, vol. 32, no. 5, article 137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Q.-H. Wang, Z.-G. Ji, H.-Z. Li et al., “Clinicopathologic comparison of urothelial bladder carcinoma in young and elder patients,” Pathology and Oncology Research, vol. 22, no. 1, pp. 67–70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-C. Wen, J.-Y. Kuo, K.-K. Chen et al., “Urothelial carcinoma of the urinary bladder in young adults-clinical experience at Taipei Veterans General Hospital,” Journal of the Chinese Medical Association, vol. 68, no. 6, pp. 272–275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Nomikos, A. Pappas, M.-E. Kopaka et al., “Urothelial carcinoma of the urinary bladder in young adults: presentation, clinical behavior and outcome,” Advances in Urology, vol. 2011, Article ID 480738, 4 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Compérat, S. Larré, M. Roupret et al., “Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old,” Virchows Archiv, vol. 466, no. 5, pp. 589–594, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Poletajew, M. Walędziak, Ł. Fus, P. Pomada, J. Ciechańska, and A. Wasiutyński, “Urothelial bladder carcinoma in young patients is characterized by a relatively good prognosis,” Upsala Journal of Medical Sciences, vol. 117, no. 1, pp. 47–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Cheng, R. Montironi, D. D. Davidson, and A. Lopez-Beltran, “Staging and reporting of urothelial carcinoma of the urinary bladder,” Modern Pathology, vol. 22, supplement 2, pp. S70–S95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. I. Epstein, M. B. Amin, V. R. Reuter et al., “The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder,” The American Journal of Surgical Pathology, vol. 22, no. 12, pp. 1435–1448, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. A. Lee, H. S. U. Kim, M. Kim, and J. H. Y. Ku, “External validation of a clinical scoring system for hematuria,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 16, pp. 6819–6822, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Z.-H. Wang, Y.-Y. Li, Z.-Q. Hu et al., “Does urothelial cancer of bladder behave differently in young patients?” Chinese Medical Journal, vol. 125, no. 15, pp. 2643–2648, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Otunctemur, I. Koklu, E. Ozbek et al., “Are bladder neoplasms more aggresive in patients with a smoking-related second malignancy?” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 9, pp. 4025–4028, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. N. D. Freedman, D. T. Silverman, A. R. Hollenbeck, A. Schatzkin, and C. C. Abnet, “Association between smoking and risk of bladder cancer among men and women,” JAMA, vol. 306, no. 7, pp. 737–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Migaldi, G. Rossi, A. Maiorana et al., “Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study,” BJU International, vol. 94, no. 3, pp. 311–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Yossepowitch and G. Dalbagni, “Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome,” Journal of Urology, vol. 168, no. 1, pp. 61–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. P. Paner, P. Zehnder, A. M. Amin, A. N. Husain, and M. M. Desai, “Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management,” Advances in Anatomic Pathology, vol. 18, no. 1, pp. 79–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. C. Benson Jr., K. M. Tomera, and P. P. Kelalis, “Transitional cell carcinoma of the bladder in children and adolescents,” Journal of Urology, vol. 130, no. 1, pp. 54–55, 1983. View at Google Scholar · View at Scopus
  22. V. Sen, O. Bozkurt, O. Demir et al., “Prognostic significance of nestin expression in pT1 high-grade bladder urothelial carcinoma patients treated with intravesical BCG,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 24, pp. 10813–10817, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Lima, M. Dinis-Ribeiro, A. Longatto-Filho, and L. Santos, “Predictive biomarkers of bacillus Calmette-Guérin immunotherapy response in bladder cancer: where are we now?” Advances in Urology, vol. 2012, Article ID 232609, 17 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Mammadov, G. Aslan, B. Tuna, O. Bozkurt, and K. Yorukoglu, “Can recurrence and progression be predicted by HYAL-1 expression in primary T1 bladder cancer?” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 23, pp. 10401–10405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Christensen, M. A. Jensen, H. Wolf, and T. F. Ørntoft, “Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer,” International Journal of Cancer, vol. 79, no. 4, pp. 396–401, 1998. View at Publisher · View at Google Scholar · View at Scopus